nbp2 (Novus Biologicals)
93
Structured Review
Novus Biologicals
nbp2
Nbp2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/node/Peripheral+Node+Addressin+Antibody+(MECA-79R)+-+BSA+Free/pmc12281385-25-10-7
Average 93 stars, based on 1 article reviews
Nbp2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/node/Peripheral+Node+Addressin+Antibody+(MECA-79R)+-+BSA+Free/pmc12281385-25-10-7
Average 93 stars, based on 1 article reviews
nbp2 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody Article Snippet: The detection was performed using a DAB detection kit (Ventana Medical Systems) or Alexa Fluor 488 or 568 Tyramide Reagent (Invitrogen). .. IHC staining of peripheral node addressin (PNA) (MECA79) was done with a manual protocol at Laboratory of Comparative Pathology using Staining:Article Title: Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody Article Snippet: The detection was performed using a DAB detection kit (Ventana Medical Systems) or Alexa Fluor 488 or 568 Tyramide Reagent (Invitrogen). .. IHC staining of peripheral node addressin (PNA) (MECA79) was done with a manual protocol at Laboratory of Comparative Pathology using other:Article Title: Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma Article Snippet: Rat Monoclonal Peripheral Node Addressin Antibody , Recombinant:Article Title: Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-human CD45 Cell Signaling Technology Cat# 13917; RRID: |